Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cortical Spreading Depression | 70 | 2023 | 276 | 20.560 |
Why?
|
Migraine with Aura | 19 | 2022 | 203 | 4.720 |
Why?
|
Migraine Disorders | 33 | 2023 | 1620 | 4.560 |
Why?
|
Cerebrovascular Circulation | 48 | 2023 | 2732 | 4.480 |
Why?
|
Brain Ischemia | 40 | 2023 | 3264 | 4.290 |
Why?
|
Infarction, Middle Cerebral Artery | 18 | 2023 | 476 | 2.930 |
Why?
|
Stroke | 44 | 2024 | 9975 | 2.650 |
Why?
|
Subarachnoid Hemorrhage | 11 | 2023 | 1018 | 2.590 |
Why?
|
Vagus Nerve Stimulation | 6 | 2023 | 200 | 2.030 |
Why?
|
Disease Models, Animal | 51 | 2023 | 18027 | 1.840 |
Why?
|
Cerebral Cortex | 22 | 2023 | 5692 | 1.670 |
Why?
|
Hyperalgesia | 3 | 2023 | 502 | 1.620 |
Why?
|
CADASIL | 4 | 2022 | 84 | 1.590 |
Why?
|
Calcium Channels, N-Type | 6 | 2015 | 39 | 1.460 |
Why?
|
Headache | 7 | 2024 | 1224 | 1.340 |
Why?
|
Animals | 155 | 2023 | 168660 | 1.340 |
Why?
|
Mice | 99 | 2023 | 81154 | 1.250 |
Why?
|
Cerebral Infarction | 8 | 2020 | 1011 | 1.220 |
Why?
|
Arterioles | 9 | 2021 | 254 | 1.190 |
Why?
|
Endothelin-1 | 6 | 2020 | 314 | 1.070 |
Why?
|
Rats, Sprague-Dawley | 31 | 2023 | 8300 | 1.050 |
Why?
|
Mice, Inbred C57BL | 47 | 2020 | 21824 | 1.030 |
Why?
|
Oxygen | 11 | 2019 | 4189 | 1.020 |
Why?
|
Somatosensory Cortex | 5 | 2019 | 525 | 1.020 |
Why?
|
Brain | 36 | 2023 | 26345 | 1.020 |
Why?
|
Aneurysm, Ruptured | 2 | 2020 | 452 | 0.990 |
Why?
|
rho-Associated Kinases | 4 | 2022 | 279 | 0.960 |
Why?
|
Rats | 42 | 2023 | 24250 | 0.920 |
Why?
|
Cerebrovascular Disorders | 5 | 2015 | 1504 | 0.890 |
Why?
|
Vasospasm, Intracranial | 2 | 2020 | 208 | 0.880 |
Why?
|
Vasodilation | 5 | 2020 | 944 | 0.860 |
Why?
|
Cerebral Hemorrhage | 5 | 2023 | 2647 | 0.850 |
Why?
|
NAD | 3 | 2023 | 590 | 0.830 |
Why?
|
Leukoaraiosis | 1 | 2022 | 118 | 0.770 |
Why?
|
Gene Knock-In Techniques | 4 | 2021 | 418 | 0.760 |
Why?
|
Laser-Doppler Flowmetry | 16 | 2018 | 242 | 0.740 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1197 | 0.740 |
Why?
|
Hypoxia, Brain | 4 | 2018 | 133 | 0.730 |
Why?
|
Regional Blood Flow | 6 | 2018 | 1525 | 0.720 |
Why?
|
Hyperoxia | 3 | 2014 | 262 | 0.720 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2011 | 141 | 0.710 |
Why?
|
Anticonvulsants | 4 | 2017 | 1910 | 0.710 |
Why?
|
Receptors, Notch | 6 | 2022 | 739 | 0.700 |
Why?
|
Anesthetics | 3 | 2019 | 539 | 0.670 |
Why?
|
Amines | 2 | 2011 | 276 | 0.670 |
Why?
|
Maze Learning | 4 | 2020 | 478 | 0.660 |
Why?
|
Neurons | 15 | 2019 | 9336 | 0.650 |
Why?
|
Mice, Transgenic | 12 | 2023 | 9731 | 0.650 |
Why?
|
Transcytosis | 1 | 2018 | 44 | 0.650 |
Why?
|
Cerebral Arteries | 4 | 2019 | 494 | 0.640 |
Why?
|
Hyperlipidemias | 2 | 2013 | 789 | 0.630 |
Why?
|
Capillaries | 2 | 2021 | 773 | 0.630 |
Why?
|
Tomography, Optical Coherence | 5 | 2021 | 2657 | 0.610 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 53 | 0.590 |
Why?
|
Male | 103 | 2024 | 349776 | 0.580 |
Why?
|
Caveolin 1 | 1 | 2018 | 263 | 0.570 |
Why?
|
Behavior, Animal | 4 | 2020 | 1880 | 0.570 |
Why?
|
Brain Injuries | 10 | 2022 | 2029 | 0.560 |
Why?
|
Oxygen Consumption | 5 | 2014 | 1869 | 0.560 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2013 | 57 | 0.550 |
Why?
|
Hypotension | 3 | 2012 | 884 | 0.540 |
Why?
|
Endothelium | 1 | 2018 | 777 | 0.530 |
Why?
|
Pericytes | 1 | 2018 | 293 | 0.530 |
Why?
|
Arteries | 2 | 2020 | 1119 | 0.530 |
Why?
|
Nitric Oxide Synthase | 11 | 2004 | 915 | 0.520 |
Why?
|
Ischemic Attack, Transient | 7 | 2023 | 934 | 0.510 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2016 | 841 | 0.510 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2011 | 1118 | 0.500 |
Why?
|
Membrane Potentials | 3 | 2015 | 1137 | 0.490 |
Why?
|
Internal Capsule | 1 | 2015 | 113 | 0.480 |
Why?
|
CA1 Region, Hippocampal | 1 | 2015 | 112 | 0.480 |
Why?
|
N-Methylaspartate | 5 | 2005 | 231 | 0.480 |
Why?
|
Sodium, Dietary | 1 | 2018 | 418 | 0.480 |
Why?
|
Neuroprotective Agents | 6 | 2016 | 941 | 0.460 |
Why?
|
Potassium Chloride | 5 | 2011 | 237 | 0.450 |
Why?
|
Vibrissae | 5 | 2019 | 126 | 0.450 |
Why?
|
Long-Term Potentiation | 1 | 2015 | 293 | 0.450 |
Why?
|
Depression | 3 | 2023 | 7760 | 0.440 |
Why?
|
Analgesics | 4 | 2022 | 1040 | 0.440 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2021 | 859 | 0.440 |
Why?
|
Excitatory Amino Acid Antagonists | 4 | 2020 | 449 | 0.430 |
Why?
|
Fructose | 1 | 2014 | 287 | 0.430 |
Why?
|
Triazines | 1 | 2014 | 315 | 0.430 |
Why?
|
Hyperemia | 5 | 2019 | 225 | 0.430 |
Why?
|
Visual Cortex | 1 | 2020 | 1136 | 0.420 |
Why?
|
Models, Neurological | 5 | 2020 | 1771 | 0.420 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1404 | 0.420 |
Why?
|
Wakefulness | 1 | 2019 | 1243 | 0.420 |
Why?
|
Conditioning, Classical | 1 | 2015 | 366 | 0.410 |
Why?
|
Motor Skills | 1 | 2015 | 522 | 0.400 |
Why?
|
Corpus Callosum | 4 | 2022 | 736 | 0.400 |
Why?
|
Motor Cortex | 1 | 2019 | 986 | 0.400 |
Why?
|
Thalamus | 2 | 2015 | 1023 | 0.400 |
Why?
|
Magnetic Resonance Imaging | 17 | 2021 | 35409 | 0.390 |
Why?
|
Carbamazepine | 2 | 2010 | 229 | 0.390 |
Why?
|
Electric Stimulation | 8 | 2019 | 1760 | 0.380 |
Why?
|
Endothelium, Vascular | 6 | 2019 | 4459 | 0.380 |
Why?
|
Vasoconstrictor Agents | 2 | 2019 | 642 | 0.380 |
Why?
|
Blood-Brain Barrier | 5 | 2018 | 1018 | 0.370 |
Why?
|
Reperfusion Injury | 5 | 2019 | 1027 | 0.360 |
Why?
|
Pancreatic Elastase | 2 | 2020 | 136 | 0.350 |
Why?
|
Mice, Knockout | 24 | 2020 | 14563 | 0.350 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2016 | 367 | 0.350 |
Why?
|
Neurotransmitter Agents | 3 | 2017 | 646 | 0.350 |
Why?
|
Perfusion | 3 | 2018 | 1359 | 0.340 |
Why?
|
Estrogens | 2 | 2023 | 1563 | 0.340 |
Why?
|
Pia Mater | 3 | 2005 | 88 | 0.340 |
Why?
|
Enzyme Inhibitors | 8 | 2017 | 3794 | 0.330 |
Why?
|
Progesterone | 2 | 2023 | 773 | 0.330 |
Why?
|
Recovery of Function | 6 | 2022 | 2922 | 0.320 |
Why?
|
Vasoconstriction | 4 | 2019 | 597 | 0.320 |
Why?
|
Seizures | 1 | 2021 | 2850 | 0.320 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 692 | 0.320 |
Why?
|
Nitroarginine | 7 | 2004 | 66 | 0.310 |
Why?
|
Blood Vessels | 2 | 2013 | 1124 | 0.310 |
Why?
|
Paresis | 1 | 2008 | 180 | 0.300 |
Why?
|
Physical Stimulation | 4 | 2019 | 525 | 0.300 |
Why?
|
Blood Volume | 5 | 2018 | 565 | 0.300 |
Why?
|
Hemorrhage | 1 | 2019 | 3458 | 0.290 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 3 | 2015 | 271 | 0.290 |
Why?
|
Evoked Potentials | 4 | 2019 | 1022 | 0.290 |
Why?
|
Humans | 84 | 2024 | 743811 | 0.290 |
Why?
|
Neural Pathways | 3 | 2015 | 2971 | 0.290 |
Why?
|
Potassium | 4 | 2022 | 1336 | 0.280 |
Why?
|
Stress, Psychological | 2 | 2019 | 4245 | 0.280 |
Why?
|
Calcium | 2 | 2019 | 5755 | 0.280 |
Why?
|
Mutation, Missense | 2 | 2015 | 2566 | 0.280 |
Why?
|
Brain Edema | 5 | 2014 | 617 | 0.270 |
Why?
|
Inflammation | 5 | 2019 | 10629 | 0.270 |
Why?
|
Anxiety | 1 | 2020 | 4288 | 0.270 |
Why?
|
Nitric Oxide Synthase Type III | 5 | 2014 | 689 | 0.270 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2217 | 0.270 |
Why?
|
Synapses | 1 | 2015 | 1728 | 0.270 |
Why?
|
Random Allocation | 3 | 2019 | 2429 | 0.260 |
Why?
|
Simvastatin | 1 | 2008 | 360 | 0.260 |
Why?
|
Nerve Net | 2 | 2018 | 2173 | 0.260 |
Why?
|
Blood Pressure | 11 | 2019 | 8551 | 0.260 |
Why?
|
Cerebellar Ataxia | 3 | 2018 | 145 | 0.260 |
Why?
|
Hypoglycemia | 1 | 2012 | 861 | 0.260 |
Why?
|
Cerebellar Cortex | 1 | 2005 | 107 | 0.250 |
Why?
|
Foramen Ovale, Patent | 2 | 2022 | 223 | 0.250 |
Why?
|
Sulfonic Acids | 2 | 2015 | 97 | 0.240 |
Why?
|
Neuroglia | 1 | 2010 | 928 | 0.240 |
Why?
|
Point Mutation | 1 | 2009 | 1623 | 0.240 |
Why?
|
Homeostasis | 5 | 2022 | 3337 | 0.240 |
Why?
|
Estrus | 1 | 2023 | 81 | 0.230 |
Why?
|
Mutation | 8 | 2022 | 29777 | 0.230 |
Why?
|
Hyperglycemia | 1 | 2012 | 1373 | 0.230 |
Why?
|
Kainic Acid | 2 | 2021 | 199 | 0.230 |
Why?
|
Rheology | 1 | 2004 | 345 | 0.230 |
Why?
|
Glucose | 4 | 2018 | 4398 | 0.230 |
Why?
|
Calcium Channels | 4 | 2010 | 622 | 0.220 |
Why?
|
Intracranial Pressure | 2 | 2022 | 326 | 0.220 |
Why?
|
Mefenamic Acid | 1 | 2022 | 5 | 0.210 |
Why?
|
Female | 37 | 2024 | 380020 | 0.210 |
Why?
|
Research Design | 3 | 2023 | 5983 | 0.210 |
Why?
|
Thrombectomy | 2 | 2017 | 680 | 0.210 |
Why?
|
Hemodynamics | 5 | 2023 | 4197 | 0.200 |
Why?
|
Glutamates | 1 | 2023 | 397 | 0.200 |
Why?
|
Microcirculation | 3 | 2023 | 1287 | 0.200 |
Why?
|
Bicuculline | 1 | 2021 | 94 | 0.200 |
Why?
|
Models, Genetic | 1 | 2012 | 3492 | 0.200 |
Why?
|
Blood Glucose | 2 | 2012 | 6259 | 0.190 |
Why?
|
Desoxycorticosterone | 1 | 2020 | 50 | 0.190 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2019 | 1503 | 0.190 |
Why?
|
4-Aminopyridine | 1 | 2021 | 81 | 0.190 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 64 | 0.190 |
Why?
|
Leukoencephalopathies | 2 | 2014 | 238 | 0.190 |
Why?
|
Tetrodotoxin | 2 | 2021 | 259 | 0.190 |
Why?
|
Receptors, GABA-A | 2 | 2023 | 627 | 0.190 |
Why?
|
Potassium Channel Blockers | 1 | 2021 | 171 | 0.190 |
Why?
|
Calcium Channels, P-Type | 1 | 2000 | 9 | 0.180 |
Why?
|
Brain Concussion | 3 | 2018 | 1320 | 0.180 |
Why?
|
Electrophysiology | 4 | 2010 | 1297 | 0.180 |
Why?
|
Dipeptides | 2 | 2020 | 409 | 0.180 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2019 | 18 | 0.180 |
Why?
|
Hematoma | 2 | 2023 | 758 | 0.180 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 352 | 0.180 |
Why?
|
Middle Cerebral Artery | 3 | 2019 | 264 | 0.180 |
Why?
|
Migraine without Aura | 1 | 2020 | 83 | 0.170 |
Why?
|
Testosterone | 1 | 2009 | 2297 | 0.170 |
Why?
|
Pain Threshold | 1 | 2023 | 584 | 0.170 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2019 | 192 | 0.160 |
Why?
|
Electroencephalography | 6 | 2020 | 6061 | 0.160 |
Why?
|
Cluster Headache | 1 | 2019 | 54 | 0.160 |
Why?
|
Hippocampus | 5 | 2019 | 3672 | 0.160 |
Why?
|
Neovascularization, Physiologic | 2 | 2018 | 1351 | 0.160 |
Why?
|
Acute Disease | 3 | 2019 | 7150 | 0.160 |
Why?
|
Penicillins | 1 | 2021 | 380 | 0.160 |
Why?
|
Ischemia | 3 | 2023 | 1907 | 0.160 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2020 | 306 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 5 | 2019 | 17439 | 0.160 |
Why?
|
Apolipoproteins E | 2 | 2014 | 1436 | 0.160 |
Why?
|
Endothelins | 1 | 2018 | 138 | 0.160 |
Why?
|
Rats, Inbred SHR | 1 | 2018 | 195 | 0.160 |
Why?
|
Ligation | 2 | 2018 | 452 | 0.150 |
Why?
|
Hypercapnia | 3 | 2007 | 260 | 0.150 |
Why?
|
Free Radicals | 1 | 2018 | 237 | 0.150 |
Why?
|
Neuromuscular Nondepolarizing Agents | 2 | 2015 | 146 | 0.150 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2017 | 23 | 0.150 |
Why?
|
Nervous System | 1 | 2021 | 554 | 0.150 |
Why?
|
Vagus Nerve | 1 | 2020 | 439 | 0.150 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2020 | 251 | 0.150 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12259 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5532 | 0.150 |
Why?
|
Monitoring, Physiologic | 3 | 2018 | 1738 | 0.150 |
Why?
|
Sodium Chloride, Dietary | 1 | 2019 | 281 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2017 | 85 | 0.150 |
Why?
|
Carotid Artery, Common | 1 | 2018 | 183 | 0.140 |
Why?
|
Critical Care | 2 | 2016 | 2647 | 0.140 |
Why?
|
Excitatory Amino Acid Agonists | 4 | 2005 | 146 | 0.140 |
Why?
|
Injections | 1 | 2020 | 839 | 0.140 |
Why?
|
Mice, Neurologic Mutants | 2 | 2011 | 126 | 0.140 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2019 | 688 | 0.140 |
Why?
|
Animals, Genetically Modified | 2 | 2012 | 1552 | 0.140 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 132 | 0.140 |
Why?
|
gamma-Cyclodextrins | 1 | 2015 | 17 | 0.140 |
Why?
|
Aconitine | 1 | 1995 | 4 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2914 | 0.140 |
Why?
|
Tight Junctions | 1 | 2018 | 311 | 0.130 |
Why?
|
Sex Factors | 3 | 2020 | 10394 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2016 | 2739 | 0.130 |
Why?
|
Estradiol | 1 | 2023 | 2017 | 0.130 |
Why?
|
Brain Stem | 1 | 2021 | 844 | 0.130 |
Why?
|
Hydroquinones | 1 | 2015 | 36 | 0.130 |
Why?
|
Calcium-Transporting ATPases | 1 | 2015 | 123 | 0.130 |
Why?
|
Glutamic Acid | 3 | 2022 | 1168 | 0.130 |
Why?
|
Connexins | 1 | 2017 | 357 | 0.130 |
Why?
|
Astrocytes | 2 | 2015 | 1273 | 0.130 |
Why?
|
Disease Susceptibility | 3 | 2011 | 1781 | 0.130 |
Why?
|
Long-Term Synaptic Depression | 1 | 2015 | 59 | 0.130 |
Why?
|
Dogs | 1 | 2020 | 3911 | 0.130 |
Why?
|
Acetylcholine | 3 | 2006 | 619 | 0.130 |
Why?
|
Aging | 3 | 2023 | 8655 | 0.120 |
Why?
|
Deferoxamine | 1 | 2015 | 151 | 0.120 |
Why?
|
Sirtuin 2 | 1 | 2015 | 97 | 0.120 |
Why?
|
Brain Mapping | 3 | 2019 | 6622 | 0.120 |
Why?
|
Light | 2 | 2018 | 1365 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2015 | 139 | 0.120 |
Why?
|
Benzylisoquinolines | 1 | 2013 | 15 | 0.120 |
Why?
|
Corticosterone | 1 | 2014 | 310 | 0.120 |
Why?
|
Propylene Glycols | 1 | 2014 | 92 | 0.120 |
Why?
|
Myelin Sheath | 2 | 2015 | 652 | 0.120 |
Why?
|
Quinazolines | 1 | 2020 | 1356 | 0.120 |
Why?
|
Phenotype | 4 | 2023 | 16361 | 0.120 |
Why?
|
DNA Glycosylases | 1 | 2014 | 128 | 0.120 |
Why?
|
Hypertension | 2 | 2018 | 8480 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 1 | 2015 | 270 | 0.110 |
Why?
|
Caffeine | 1 | 2018 | 699 | 0.110 |
Why?
|
Sleep Deprivation | 1 | 2020 | 831 | 0.110 |
Why?
|
Rabbits | 1 | 2020 | 4894 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2018 | 763 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3255 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2029 | 0.110 |
Why?
|
Neuromuscular Junction | 1 | 1995 | 397 | 0.110 |
Why?
|
Rest | 1 | 2018 | 901 | 0.110 |
Why?
|
Brain Infarction | 2 | 2014 | 299 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2162 | 0.110 |
Why?
|
Nitrous Oxide | 2 | 2016 | 175 | 0.110 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2013 | 130 | 0.110 |
Why?
|
Chemoprevention | 1 | 2014 | 319 | 0.110 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1285 | 0.100 |
Why?
|
Anesthesia | 2 | 2016 | 1562 | 0.100 |
Why?
|
Valproic Acid | 2 | 2010 | 445 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1601 | 0.100 |
Why?
|
Research | 2 | 2018 | 1999 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1374 | 0.100 |
Why?
|
Environment | 1 | 2018 | 1121 | 0.100 |
Why?
|
Colon | 1 | 2020 | 1772 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1170 | 0.100 |
Why?
|
Sphingosine | 1 | 2014 | 306 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2015 | 10940 | 0.100 |
Why?
|
Cell Death | 5 | 2019 | 1705 | 0.100 |
Why?
|
Isoenzymes | 1 | 1996 | 1728 | 0.100 |
Why?
|
Corpus Striatum | 1 | 1997 | 1219 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2020 | 21733 | 0.100 |
Why?
|
Oxyhemoglobins | 2 | 2011 | 216 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4463 | 0.100 |
Why?
|
Receptors, Purinergic | 1 | 2011 | 66 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2005 | 896 | 0.090 |
Why?
|
Cell Survival | 2 | 2019 | 5881 | 0.090 |
Why?
|
Energy Metabolism | 2 | 2015 | 2899 | 0.090 |
Why?
|
Warfarin | 1 | 2019 | 1497 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1619 | 0.090 |
Why?
|
Isoflurane | 2 | 2008 | 380 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2023 | 3292 | 0.090 |
Why?
|
Injections, Intravenous | 2 | 2010 | 1422 | 0.090 |
Why?
|
Signal Transduction | 6 | 2019 | 23398 | 0.090 |
Why?
|
Airway Remodeling | 1 | 2011 | 132 | 0.090 |
Why?
|
Piperazines | 1 | 2020 | 2487 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2865 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2011 | 235 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2010 | 201 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 2 | 2007 | 1263 | 0.090 |
Why?
|
Rodentia | 2 | 2023 | 261 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2172 | 0.090 |
Why?
|
Respiratory Hypersensitivity | 1 | 2011 | 273 | 0.090 |
Why?
|
Neural Stem Cells | 2 | 2013 | 851 | 0.080 |
Why?
|
Ions | 1 | 2010 | 265 | 0.080 |
Why?
|
Benzamides | 1 | 2015 | 1383 | 0.080 |
Why?
|
Hot Temperature | 1 | 2015 | 1351 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 718 | 0.080 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 314 | 0.080 |
Why?
|
Oligodendroglia | 1 | 2013 | 517 | 0.080 |
Why?
|
Swine | 1 | 2019 | 5909 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1423 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3038 | 0.080 |
Why?
|
Chloralose | 1 | 2008 | 14 | 0.080 |
Why?
|
Urethane | 1 | 2008 | 40 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2827 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2011 | 575 | 0.080 |
Why?
|
Action Potentials | 1 | 2016 | 1804 | 0.080 |
Why?
|
Time Factors | 6 | 2018 | 40038 | 0.080 |
Why?
|
Sodium Channels | 1 | 2010 | 349 | 0.080 |
Why?
|
Cell Communication | 1 | 2015 | 1621 | 0.080 |
Why?
|
Oxidative Phosphorylation | 1 | 2010 | 480 | 0.080 |
Why?
|
Plaque, Amyloid | 1 | 2011 | 729 | 0.080 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 494 | 0.080 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2007 | 534 | 0.070 |
Why?
|
Phenylephrine | 1 | 2008 | 301 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2217 | 0.070 |
Why?
|
Orchiectomy | 1 | 2009 | 468 | 0.070 |
Why?
|
Coma | 1 | 2011 | 475 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 200 | 0.070 |
Why?
|
Rats, Wistar | 3 | 2015 | 1892 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3284 | 0.070 |
Why?
|
Stimulation, Chemical | 1 | 2006 | 326 | 0.070 |
Why?
|
Memory Disorders | 1 | 2014 | 1186 | 0.070 |
Why?
|
Amyloid beta-Peptides | 2 | 2011 | 3587 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 838 | 0.070 |
Why?
|
Axons | 1 | 2015 | 1685 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
Embolism | 1 | 2010 | 407 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.070 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2006 | 254 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2050 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1694 | 0.070 |
Why?
|
Ovariectomy | 1 | 2008 | 661 | 0.070 |
Why?
|
Fear | 1 | 2015 | 1438 | 0.070 |
Why?
|
Spectrum Analysis | 1 | 2008 | 454 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12786 | 0.070 |
Why?
|
Myasthenia Gravis | 1 | 2008 | 199 | 0.070 |
Why?
|
Glycolysis | 1 | 2010 | 830 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2008 | 717 | 0.070 |
Why?
|
Dietary Fats | 1 | 2013 | 2016 | 0.070 |
Why?
|
Calcium Signaling | 1 | 2010 | 721 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2837 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5651 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6356 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1938 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2045 | 0.060 |
Why?
|
Atracurium | 2 | 2015 | 52 | 0.060 |
Why?
|
Androstanols | 2 | 2015 | 47 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2274 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2019 | 63042 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2008 | 604 | 0.060 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2015 | 1411 | 0.060 |
Why?
|
Neural Inhibition | 1 | 2008 | 598 | 0.060 |
Why?
|
Phosphorylation | 2 | 2013 | 8436 | 0.060 |
Why?
|
Anticoagulants | 1 | 2019 | 4599 | 0.060 |
Why?
|
Middle Aged | 13 | 2020 | 213241 | 0.060 |
Why?
|
Adult | 13 | 2020 | 213889 | 0.060 |
Why?
|
Thymus Gland | 1 | 2008 | 1266 | 0.060 |
Why?
|
Liver | 2 | 2019 | 7479 | 0.060 |
Why?
|
Fibrinolysis | 1 | 2004 | 322 | 0.060 |
Why?
|
Drug Design | 1 | 2008 | 1075 | 0.060 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 513 | 0.060 |
Why?
|
Dementia | 1 | 2017 | 2518 | 0.060 |
Why?
|
Caspase 3 | 3 | 2016 | 758 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2004 | 202 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2029 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 77410 | 0.050 |
Why?
|
Infarction | 1 | 2024 | 244 | 0.050 |
Why?
|
Aged | 10 | 2022 | 163178 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18355 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2006 | 974 | 0.050 |
Why?
|
Reperfusion | 4 | 2010 | 283 | 0.050 |
Why?
|
Drug Discovery | 1 | 2010 | 1058 | 0.050 |
Why?
|
Tryptamines | 1 | 2022 | 88 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2022 | 151 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1460 | 0.050 |
Why?
|
Neurologic Examination | 2 | 2018 | 929 | 0.050 |
Why?
|
Hemoglobins | 1 | 2007 | 1531 | 0.050 |
Why?
|
Troponin T | 1 | 2006 | 754 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2015 | 2785 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2020 | 12020 | 0.050 |
Why?
|
Hepatocytes | 2 | 2019 | 1211 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2011 | 2583 | 0.050 |
Why?
|
Extracellular Space | 2 | 2019 | 595 | 0.050 |
Why?
|
Iontophoresis | 2 | 1997 | 74 | 0.050 |
Why?
|
Diethylnitrosamine | 1 | 2019 | 38 | 0.050 |
Why?
|
Differential Threshold | 1 | 2000 | 80 | 0.050 |
Why?
|
Lasers | 1 | 2004 | 949 | 0.040 |
Why?
|
Receptors, Glutamate | 2 | 1997 | 232 | 0.040 |
Why?
|
Physical Examination | 1 | 2006 | 1235 | 0.040 |
Why?
|
Alleles | 1 | 2011 | 6934 | 0.040 |
Why?
|
Laboratories | 1 | 2023 | 462 | 0.040 |
Why?
|
Venules | 1 | 2019 | 165 | 0.040 |
Why?
|
Vasculitis | 1 | 2003 | 519 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2020 | 236 | 0.040 |
Why?
|
Genotype | 2 | 2011 | 12944 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4221 | 0.040 |
Why?
|
Forelimb | 3 | 2009 | 122 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 3000 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7185 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 647 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 752 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1469 | 0.040 |
Why?
|
Spin Labels | 1 | 2019 | 332 | 0.040 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2018 | 165 | 0.040 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 70 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4931 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11360 | 0.040 |
Why?
|
Cognition | 3 | 2023 | 6759 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2019 | 19232 | 0.040 |
Why?
|
Hydroxyl Radical | 1 | 1997 | 78 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1676 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6584 | 0.040 |
Why?
|
Angiography | 2 | 2015 | 1638 | 0.040 |
Why?
|
Functional Laterality | 2 | 2018 | 2280 | 0.040 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 1999 | 243 | 0.040 |
Why?
|
DNA Damage | 2 | 2019 | 2429 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 1997 | 176 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 1997 | 240 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2013 | 637 | 0.040 |
Why?
|
Nitric Oxide | 3 | 2010 | 2132 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9718 | 0.040 |
Why?
|
Mitochondria | 1 | 2010 | 3513 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 190 | 0.040 |
Why?
|
History, 19th Century | 1 | 2019 | 720 | 0.040 |
Why?
|
Cyclic GMP | 1 | 1998 | 408 | 0.040 |
Why?
|
Radio Waves | 1 | 2018 | 251 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2019 | 844 | 0.040 |
Why?
|
Goblet Cells | 1 | 2019 | 287 | 0.030 |
Why?
|
Arginine | 2 | 1998 | 943 | 0.030 |
Why?
|
Fever | 1 | 2004 | 1616 | 0.030 |
Why?
|
Vecuronium Bromide | 1 | 2015 | 33 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2017 | 6237 | 0.030 |
Why?
|
Dihydropyridines | 1 | 1996 | 67 | 0.030 |
Why?
|
Neurotoxins | 1 | 1997 | 237 | 0.030 |
Why?
|
Ischemic Preconditioning | 1 | 2016 | 92 | 0.030 |
Why?
|
Microelectrodes | 1 | 1997 | 304 | 0.030 |
Why?
|
Neuritis | 1 | 1995 | 36 | 0.030 |
Why?
|
Neostigmine | 1 | 2015 | 69 | 0.030 |
Why?
|
GABA Agents | 1 | 1995 | 42 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2022 | 5078 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2018 | 3758 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2018 | 675 | 0.030 |
Why?
|
Spinal Cord | 1 | 2003 | 1809 | 0.030 |
Why?
|
Pilot Projects | 1 | 2008 | 8316 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2015 | 96 | 0.030 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 1995 | 103 | 0.030 |
Why?
|
Reactive Nitrogen Species | 1 | 2014 | 35 | 0.030 |
Why?
|
Models, Biological | 2 | 2010 | 9582 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 173 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2000 | 1729 | 0.030 |
Why?
|
Risk Factors | 3 | 2019 | 72252 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 1995 | 324 | 0.030 |
Why?
|
Pain | 1 | 2010 | 4987 | 0.030 |
Why?
|
Trigeminal Ganglion | 1 | 1995 | 186 | 0.030 |
Why?
|
Time | 1 | 2016 | 542 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 1157 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15281 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 430 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 563 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2015 | 387 | 0.030 |
Why?
|
Substance P | 1 | 1995 | 335 | 0.030 |
Why?
|
Head Injuries, Closed | 1 | 2015 | 139 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 383 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2014 | 475 | 0.030 |
Why?
|
Antimutagenic Agents | 1 | 2013 | 7 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2006 | 1911 | 0.030 |
Why?
|
Ketamine | 1 | 2020 | 501 | 0.030 |
Why?
|
Caspases | 1 | 1997 | 928 | 0.030 |
Why?
|
Dura Mater | 1 | 1995 | 291 | 0.030 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2013 | 14 | 0.030 |
Why?
|
Macrocyclic Compounds | 1 | 2013 | 72 | 0.030 |
Why?
|
HMGB1 Protein | 1 | 2014 | 134 | 0.030 |
Why?
|
Cobalt | 1 | 2013 | 158 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1532 | 0.030 |
Why?
|
Tyrosine | 1 | 1997 | 1462 | 0.030 |
Why?
|
Autoradiography | 3 | 1999 | 745 | 0.030 |
Why?
|
Myocardium | 1 | 2006 | 4775 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2014 | 302 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2954 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 437 | 0.030 |
Why?
|
Algorithms | 3 | 2011 | 13869 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4974 | 0.030 |
Why?
|
Lung | 1 | 2011 | 9858 | 0.030 |
Why?
|
Amyloid | 1 | 2017 | 795 | 0.030 |
Why?
|
Neuromuscular Blockade | 1 | 2013 | 146 | 0.030 |
Why?
|
Tissue Distribution | 3 | 2004 | 2327 | 0.030 |
Why?
|
Insulysin | 1 | 2011 | 50 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2281 | 0.030 |
Why?
|
Anesthetics, Inhalation | 1 | 1997 | 569 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1995 | 798 | 0.030 |
Why?
|
Alum Compounds | 1 | 2011 | 33 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9139 | 0.020 |
Why?
|
History, 20th Century | 1 | 2019 | 2736 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2013 | 497 | 0.020 |
Why?
|
Optical Phenomena | 1 | 2011 | 107 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 514 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2013 | 216 | 0.020 |
Why?
|
Meclizine | 1 | 2010 | 13 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29052 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.020 |
Why?
|
Nanostructures | 1 | 2015 | 552 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2177 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1181 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 896 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19894 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2598 | 0.020 |
Why?
|
Ovalbumin | 1 | 2011 | 719 | 0.020 |
Why?
|
Partial Pressure | 1 | 2009 | 254 | 0.020 |
Why?
|
Thymus Extracts | 1 | 2008 | 2 | 0.020 |
Why?
|
Neprilysin | 1 | 2011 | 439 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2013 | 792 | 0.020 |
Why?
|
Galactose | 1 | 2010 | 306 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57744 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2015 | 723 | 0.020 |
Why?
|
Binding Sites | 1 | 1997 | 6111 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14714 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3680 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15067 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15993 | 0.020 |
Why?
|
Presenilin-1 | 1 | 2011 | 635 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6380 | 0.020 |
Why?
|
Attention | 1 | 2018 | 2393 | 0.020 |
Why?
|
Carotid Stenosis | 1 | 2015 | 854 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1911 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1008 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2007 | 135 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2008 | 5973 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3874 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2684 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 544 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 2961 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6750 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2304 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3690 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2077 | 0.020 |
Why?
|
Iodine Radioisotopes | 2 | 2004 | 1035 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 405 | 0.020 |
Why?
|
Keratins | 1 | 2008 | 515 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 644 | 0.020 |
Why?
|
Systems Integration | 1 | 2008 | 440 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1254 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2007 | 528 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21675 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 1121 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2008 | 644 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2638 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2455 | 0.020 |
Why?
|
Heart Rate | 2 | 2013 | 4091 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3744 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2007 | 471 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2018 | 3482 | 0.020 |
Why?
|
Alanine | 1 | 2007 | 571 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9272 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3574 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 193 | 0.020 |
Why?
|
Shivering | 1 | 2004 | 11 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2883 | 0.020 |
Why?
|
Tail | 1 | 2004 | 97 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10477 | 0.010 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2003 | 69 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1903 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1996 | 936 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56392 | 0.010 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 263 | 0.010 |
Why?
|
Serine | 1 | 2007 | 825 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10380 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7908 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13980 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3587 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2625 | 0.010 |
Why?
|
Electric Impedance | 2 | 1997 | 729 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1213 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5986 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2006 | 1586 | 0.010 |
Why?
|
Cell Separation | 1 | 2008 | 1750 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2014 | 1968 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2004 | 570 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 505 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85729 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 2004 | 445 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1642 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12066 | 0.010 |
Why?
|
Observer Variation | 1 | 2007 | 2592 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12788 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1836 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2006 | 832 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2003 | 533 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1995 | 4925 | 0.010 |
Why?
|
Aorta | 1 | 2008 | 2062 | 0.010 |
Why?
|
Particle Size | 1 | 2004 | 1639 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15211 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1588 | 0.010 |
Why?
|
Compliance | 1 | 1999 | 104 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4162 | 0.010 |
Why?
|
Ventilation | 1 | 1999 | 127 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2013 | 4041 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1851 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16674 | 0.010 |
Why?
|
Quinuclidinyl Benzilate | 1 | 1998 | 19 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7270 | 0.010 |
Why?
|
Prospective Studies | 2 | 2018 | 53250 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 642 | 0.010 |
Why?
|
Citrulline | 1 | 1998 | 105 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2003 | 594 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1998 | 156 | 0.010 |
Why?
|
Cathepsin B | 1 | 1997 | 82 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1997 | 374 | 0.010 |
Why?
|
Glass | 1 | 1997 | 114 | 0.010 |
Why?
|
Tritium | 1 | 1997 | 745 | 0.010 |
Why?
|
Magnetics | 1 | 1999 | 604 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13691 | 0.010 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1996 | 36 | 0.010 |
Why?
|
Calcium Channel Agonists | 1 | 1996 | 29 | 0.010 |
Why?
|
Indazoles | 1 | 1998 | 290 | 0.010 |
Why?
|
Caspase 1 | 1 | 1997 | 224 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7324 | 0.010 |
Why?
|
Muscimol | 1 | 1995 | 69 | 0.010 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1995 | 62 | 0.010 |
Why?
|
GABA-A Receptor Agonists | 1 | 1995 | 84 | 0.010 |
Why?
|
GABA Agonists | 1 | 1995 | 111 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1999 | 1150 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39001 | 0.010 |
Why?
|
Baclofen | 1 | 1995 | 129 | 0.010 |
Why?
|
Administration, Topical | 1 | 1996 | 689 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3503 | 0.010 |
Why?
|
Capsaicin | 1 | 1995 | 232 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1862 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1996 | 1826 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1997 | 1263 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1997 | 949 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12954 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1999 | 1403 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 11478 | 0.010 |
Why?
|
Ion Channels | 1 | 1996 | 1056 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2011 | 8035 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5179 | 0.010 |
Why?
|
Disease Progression | 1 | 2003 | 13273 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2006 | 11708 | 0.000 |
Why?
|
Gene Expression | 1 | 1997 | 7793 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15142 | 0.000 |
Why?
|